Genetic variants of the renin-angiotensin system, diabetic nephropathy and hypertension

Diabetologia

Volumn 40, Issue 2, 1997, Pages 193-199

  Ringel, J ^a   Beige, J ^a   Kunz, R ^a   Distler, A ^a   Sharma, A M ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Angiotensin converting enzyme; Angiotensinogen; Diabetes mellitus; Genes; Genetic; Hypertension; Insulin dependent; Nephropathy; Non insulin dependent

Indexed keywords

ANGIOTENSINOGEN;

ADULT; ARTICLE; DIABETIC NEPHROPATHY; FEMALE; GENOTYPE; HUMAN; HUMAN GENETICS; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADULT; AGED; ALLELES; ANGIOTENSINOGEN; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; PROSPECTIVE STUDIES; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS;

EID: 0031038370     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050662     Document Type: Article

References (32)

1. Seaquist ER, Goetz FC, Rich S, Barbosa J (1989) Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320: 1161-1165
2. Krolewski AS, Canessa M, Warram JH, Laffel LM, Christlieb AR, Knowler WC, Rand LI (1988) Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 318: 140-145
3. Sealey J, Laragh JH (1990) The renin-angiotensin-aldosterone system for normal regulation of blood pressure and sodium and potassium homeostasis. In: Laragh JH, Brenner BM (eds) Hypertension: pathophysiology, diagnosis and management. Raven Press, New York, pp 1287-1318
4. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 329: 1456-1462
5. Parving HH, Rossing P, Hommel E, Smidt UM (1995) Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience. Am J Kidney Dis 26: 99-107
6. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F (1992) Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51: 197-205
7. Rigat B, Hubert C, Alhenc Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86: 1343-1346
8. Schunkert H, Hense HW, Holmer SR et al. (1994) Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 330: 1634-1638
9. Cambien F, Poirier O, Lecerf L et al. (1992) Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359: 641-644
10. Markus HS, Barley J, Lunt R, Bland JM, Jeffery S, Carter ND, Brown MM (1995) Angiotensin-converting enzyme gene deletion polymorphism: a new risk factor for lacunar stroke but not carotid atheroma. Stroke 26: 1329-1333
11. Jeunemaitre X, Soubrier F, Kotelevtsev YV et al. (1992) Molecular basis of human hypertension: role of angiotensinogen. Cell 71: 169-180
12. Marre M, Bernadet P, Gallois Yet al. (1994) Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43: 384-388
13. Schmidt S, Schöne N, Ritz E, Diabetic Nephropathy Study Group (1995) Association of ACE gene polymorphism and diabetic nephropathy. Kidney Int 47: 1176-1181
14. Mizuiri S, Hemmi H, Inoue A et al. (1995) Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron 70: 455-459
15. McLaughlin KJ, Jagger C, Small M, Jardine AG (1995) Effect of angiotensinogen gene T235 variant on the development of diabetic complications in type II diabetes mellitus. Lancet 346: 1160
16. Tarnow L, Cambien F, Rossing P et al. (1995) Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 44: 489-494
17. Doi Y, Yoshizumi H, Yoshinari M et al. (1996) Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia 39: 97-102
18. Ohno T, Kawazu S, Tomono S (1996) Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics. Metabolism 45: 218-222
19. Yorioka T, Suehiro T, Yasuoka N, Hashimoto K, Kawada M (1995) Polymorphism of the angiotensin converting enzyme gene and clinical aspects of IgA nephropathy. Clin Nephrol 44: 80-85
20. Yoshida H, Mitarai T, Kawamura T et al. (1995) Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 96: 2162-2169
21. Harden PN, Geddes C, Rowe PA et al. (1995) Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet 345: 1540-1542
22. WHO Expert Committee on Diabetes Mellitus (1980) World Health Organisation Technical Report Series 640 Geneva
23. Shanmugam V, Sell KW, Saha BK (1993) Mistyping ACE heterozygotes. PCR Methods Appl 3: 120-121
24. Schmidt S, Sharma AM, Zilch O et al. (1995) Association of M235T variant of the angiotensinogen gene with familial hypertension of early onset. Nephrol Dial Transplant 10: 1145-1148
25. Schlesselmann II (1982) Sample size and power for equal and unequal case-control ratio. In: monography Case-control studies. Oxford University Press, New York, pp 144-170
26. Forsblom CM, Groop PH, Ekstrand A, Groop LC (1992) Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration. Br Med J 305: 1051-1053
27. Lane PH, Steffes MW, Mauer SM (1992) Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion. Diabetes 41: 581-586
28. Parving HH, Gall MA, Skott P (1987) Prevalence and causes of albuminuria in non-insulin dependent diabetic patients. Kidney Int 41: 758-762
29. Ruiz J, Blanche H, Cohen N et al. (1994) Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A 91: 3662-3665
30. Kario K, Kanai N, Saito K, Nago N, Matsuo T, Shimada K (1996) Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives. Circulation 93: 1630-1633
31. Nesto RW, Phillips RT, Kett KG, Hill T, Perper E, Young E, Leland OS, Jr (1988) Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: assessment by exercise thallium scintigraphy. Ann Intern Med 108: 170-175
32. Mogyorosi A, Ziyadeh FN (1996) Update on pathogenesis, markers and management of diabetic nephropathy. Curr Opin Nephrol Hypertens 5: 243-253